term,gene_name,P-value
Kaposi sarcoma-associated herpesvirus infection,CDKN1A;IFNB1;FOS;PTGS2;FGF2;HIF1A;RELA;IKBKB;IL6;CREB1;CASP3;CALM2;TP53;TLR3,7.31E-16
TNF signaling pathway,IKBKB;IL6;CEBPB;CREB1;IFNB1;CASP3;FOS;PTGS2;TNF;RELA,1.70E-12
Lipid and atherosclerosis,SELP;IKBKB;IL6;NOS3;IFNB1;CASP3;FOS;CALM2;TP53;TNF;ATF6;RELA,2.36E-12
Hepatitis B,IKBKB;IL6;CDKN1A;CREB1;IFNB1;CASP3;FOS;TP53;TNF;TLR3;RELA,2.49E-12
Pathways in cancer,CDKN1A;NOS2;GSTP1;FOS;PTGS2;FGF2;HIF1A;IL2;RELA;IL4;IKBKB;IL6;RAD51;CASP3;CALM2;TP53,4.32E-12
IL-17 signaling pathway,IL4;IKBKB;IL6;CEBPB;CASP3;FOS;PTGS2;TNF;RELA,1.25E-11
Chagas disease,IL10;IKBKB;IL6;NOS2;IFNB1;FOS;TNF;IL2;RELA,2.64E-11
PI3K-Akt signaling pathway,CDKN1A;BDNF;NOS3;IFNB1;NGF;FGF2;IL2;RELA;IL4;IKBKB;IL6;CREB1;TP53,5.11E-11
Pertussis,IL10;IL6;NOS2;CASP3;FOS;CALM2;TNF;RELA,8.54E-11
Human cytomegalovirus infection,IKBKB;IL6;CDKN1A;CREB1;IFNB1;CASP3;PTGS2;CALM2;TP53;TNF;RELA,8.78E-11
Tuberculosis,IL10;IL6;CEBPB;CREB1;NOS2;IFNB1;CASP3;CALM2;TNF;RELA,1.95E-10
Apoptosis,IKBKB;PARP1;CASP3;FOS;NGF;TP53;TNF;RELA;CTSB,5.23E-10
C-type lectin receptor signaling pathway,IL10;IKBKB;IL6;PTGS2;CALM2;TNF;IL2;RELA,1.09E-09
JAK-STAT signaling pathway,IL10;IL4;IL6;CDKN1A;IFNB1;LEP;LEPR;PTPN2;IL2,1.69E-09
Adipocytokine signaling pathway,POMC;IKBKB;LEP;NPY;LEPR;TNF;RELA,1.80E-09
Leishmaniasis,IL10;IL4;NOS2;FOS;PTGS2;TNF;RELA,3.94E-09
Yersinia infection,IL10;IKBKB;IL6;IFNB1;FOS;TNF;IL2;RELA,9.77E-09
Fluid shear stress and atherosclerosis,IKBKB;NOS3;GSTP1;FOS;CALM2;TP53;TNF;RELA,1.10E-08
Measles,IKBKB;IL6;IFNB1;CASP3;FOS;TP53;IL2;RELA,1.10E-08
Small cell lung cancer,IKBKB;CDKN1A;NOS2;CASP3;PTGS2;TP53;RELA,1.38E-08
Pathways of neurodegeneration,IL6;NOS2;BDNF;CASP3;CAT;NOS1;PTGS2;CALM2;TNF;ATF6;RELA;SOD1,2.06E-08
cAMP signaling pathway,POMC;GHSR;ADCYAP1;CREB1;BDNF;NPY;FOS;CALM2;RELA,2.09E-08
Human T-cell leukemia virus 1 infection,IKBKB;IL6;CDKN1A;CREB1;FOS;TP53;TNF;IL2;RELA,2.35E-08
Non-alcoholic fatty liver disease,IKBKB;IL6;LEP;CASP3;LEPR;FOS;TNF;RELA,2.57E-08
Hepatitis C,IKBKB;CDKN1A;IFNB1;CASP3;TP53;TNF;TLR3;RELA,2.85E-08
T cell receptor signaling pathway,IL10;IL4;IKBKB;FOS;TNF;IL2;RELA,3.26E-08
Toll-like receptor signaling pathway,IKBKB;IL6;IFNB1;FOS;TNF;TLR3;RELA,3.26E-08
Coronavirus disease,SELP;IKBKB;IL6;IFNB1;FOS;TNF;IL2;TLR3;RELA,3.87E-08
Th17 cell differentiation,IL4;IKBKB;IL6;FOS;HIF1A;IL2;RELA,3.97E-08
Inflammatory bowel disease,IL10;IL4;IL6;TNF;IL2;RELA,4.96E-08
Human papillomavirus infection,IKBKB;CDKN1A;CREB1;IFNB1;CASP3;PTGS2;TP53;TNF;TLR3;RELA,6.75E-08
Neuroactive ligand-receptor interaction,POMC;GHSR;ADCYAP1;CNR1;LEP;NPY;LEPR;OPRK1;OPRM1;NR3C1,8.91E-08
Alzheimer disease,IKBKB;IL6;NOS2;CASP3;NOS1;PTGS2;CALM2;TNF;ATF6;RELA,1.85E-07
Epstein-Barr virus infection,IKBKB;IL6;CDKN1A;IFNB1;CASP3;TP53;TNF;RELA,2.00E-07
MAPK signaling pathway,IKBKB;BDNF;CASP3;FOS;NGF;TP53;TNF;FGF2;RELA,2.91E-07
Cytokine-cytokine receptor interaction,IL10;IL4;IL6;IFNB1;LEP;LEPR;NGF;TNF;IL2,2.99E-07
Cocaine addiction,CREB1;TH;MAOA;BDNF;RELA,4.17E-07
Prostate cancer,IKBKB;CDKN1A;CREB1;GSTP1;TP53;RELA,5.50E-07
AGE-RAGE signaling pathway in diabetic complications,IL6;NOS3;CASP3;TNF;F3;RELA,6.58E-07
Amoebiasis,IL10;IL6;NOS2;CASP3;TNF;RELA,7.40E-07
Influenza A,IKBKB;IL6;IFNB1;CASP3;TNF;TLR3;RELA,1.02E-06
Insulin resistance,IKBKB;IL6;CREB1;NOS3;TNF;RELA,1.04E-06
HIF-1 signaling pathway,IL6;CDKN1A;NOS2;NOS3;HIF1A;RELA,1.09E-06
Toxoplasmosis,IL10;IKBKB;NOS2;CASP3;TNF;RELA,1.28E-06
Neurotrophin signaling pathway,IKBKB;BDNF;NGF;CALM2;TP53;RELA,1.83E-06
Amphetamine addiction,CREB1;TH;MAOA;FOS;CALM2,2.34E-06
Osteoclast differentiation,IKBKB;CREB1;IFNB1;FOS;TNF;RELA,2.68E-06
Relaxin signaling pathway,CREB1;NOS2;NOS3;FOS;NOS1;RELA,2.93E-06
Dopaminergic synapse,CREB1;TH;MAOA;FOS;COMT;CALM2,3.35E-06
Pancreatic cancer,IKBKB;CDKN1A;RAD51;TP53;RELA,3.79E-06
Human immunodeficiency virus 1 infection,IKBKB;IFNB1;CASP3;FOS;CALM2;TNF;RELA,4.09E-06
Estrogen signaling pathway,POMC;CREB1;NOS3;OPRM1;FOS;CALM2,4.15E-06
Tyrosine metabolism,TH;MAOA;TYRP1;COMT,4.58E-06
Allograft rejection,IL10;IL4;TNF;IL2,5.71E-06
Th1 and Th2 cell differentiation,IL4;IKBKB;FOS;IL2;RELA,9.71E-06
Circadian entrainment,ADCYAP1;CREB1;FOS;NOS1;CALM2,1.26E-05
Intestinal immune network for IgA production,IL10;IL4;IL6;IL2,1.47E-05
Amyotrophic lateral sclerosis,NOS2;CASP3;CAT;NOS1;TP53;TNF;ATF6;SOD1,1.60E-05
Longevity regulating pathway,CREB1;CAT;TP53;RELA;SOD1,1.61E-05
Arginine and proline metabolism,NOS2;MAOA;NOS3;NOS1,1.73E-05
Malaria,IL10;SELP;IL6;TNF,1.73E-05
NF-kappa B signaling pathway,IKBKB;PARP1;PTGS2;TNF;RELA,1.76E-05
NOD-like receptor signaling pathway,IKBKB;IL6;IFNB1;TNF;RELA;CTSB,2.04E-05
Alcoholism,CREB1;TH;BDNF;MAOA;NPY;CALM2,2.38E-05
Transcriptional misregulation in cancer,IL6;CEBPB;CDKN1A;TP53;MPO;RELA,2.85E-05
Legionellosis,IL6;CASP3;TNF;RELA,2.92E-05
Pathogenic Escherichia coli infection,IKBKB;IL6;CASP3;FOS;TNF;RELA,3.29E-05
Proteoglycans in cancer,CDKN1A;CASP3;TP53;TNF;FGF2;HIF1A,4.11E-05
Arginine biosynthesis,NOS2;NOS3;NOS1,4.19E-05
Cytosolic DNA-sensing pathway,IKBKB;IL6;IFNB1;RELA,4.35E-05
FoxO signaling pathway,IL10;IKBKB;IL6;CDKN1A;CAT,5.36E-05
Renin secretion,ADCYAP1;CREB1;CALM2;CTSB,6.22E-05
RIG-I-like receptor signaling pathway,IKBKB;IFNB1;TNF;RELA,6.59E-05
Ras signaling pathway,IKBKB;BDNF;NGF;CALM2;FGF2;RELA,8.16E-05
Chronic myeloid leukemia,IKBKB;CDKN1A;TP53;RELA,9.09E-05
Chemical carcinogenesis,CREB1;GSTP1;FOS;PTGS2;FGF2;RELA,9.61E-05
Calcium signaling pathway,NOS2;NOS3;NOS1;NGF;CALM2;FGF2,9.83E-05
Oxytocin signaling pathway,CDKN1A;NOS3;FOS;PTGS2;CALM2,1.15E-04
Asthma,IL10;IL4;TNF,1.20E-04
Parkinson disease,TH;MAOA;CASP3;CALM2;TP53;ATF6,1.20E-04
Salmonella infection,IKBKB;IL6;CASP3;FOS;TNF;RELA,1.20E-04
Peroxisome,NOS2;CAT;XDH;SOD1,1.22E-04
Cellular senescence,IL6;CDKN1A;CALM2;TP53;RELA,1.22E-04
Herpes simplex virus 1 infection,IKBKB;IL6;IFNB1;CASP3;TP53;TNF;TLR3;RELA,1.45E-04
Colorectal cancer,CDKN1A;CASP3;FOS;TP53,1.47E-04
PD-L1 expression and PD-1 checkpoint pathway in cancer,IKBKB;FOS;HIF1A;RELA,1.68E-04
African trypanosomiasis,IL10;IL6;TNF,2.04E-04
Viral protein interaction with cytokine and cytokine receptor,IL10;IL6;TNF;IL2,2.63E-04
Melanogenesis,POMC;CREB1;TYRP1;CALM2,2.73E-04
Graft-versus-host disease,IL6;TNF;IL2,2.99E-04
Drug metabolism,MAOA;GSTP1;MPO;XDH,3.53E-04
MicroRNAs in cancer,TRIM71;IKBKB;CDKN1A;CASP3;PTGS2;TP53,3.92E-04
Viral carcinogenesis,CDKN1A;CREB1;CASP3;TP53;RELA,4.15E-04
Serotonergic synapse,MAOA;CASP3;PTGS2;PTGS1,4.19E-04
Sphingolipid signaling pathway,NOS3;TP53;TNF;RELA,5.09E-04
Autoimmune thyroid disease,IL10;IL4;IL2,5.95E-04
Regulation of lipolysis in adipocytes,NPY;PTGS2;PTGS1,6.63E-04
Apelin signaling pathway,NOS2;NOS3;NOS1;CALM2,8.64E-04
Shigellosis,IKBKB;IFNB1;TP53;TNF;RELA,9.88E-04
Breast cancer,CDKN1A;FOS;TP53;FGF2,1.12E-03
Acute myeloid leukemia,IKBKB;MPO;RELA,1.18E-03
Mitophagy,TP53;HIF1A;RELA,1.23E-03
Epithelial cell signaling in Helicobacter pylori infection,IKBKB;CASP3;RELA,1.34E-03
Prolactin signaling pathway,TH;FOS;RELA,1.34E-03
Melanoma,CDKN1A;TP53;FGF2,1.45E-03
Necroptosis,PARP1;IFNB1;TNF;TLR3,1.50E-03
p53 signaling pathway,CDKN1A;CASP3;TP53,1.51E-03
Prion disease,IL6;CREB1;CASP3;TNF;SOD1,1.57E-03
Glioma,CDKN1A;CALM2;TP53,1.63E-03
Antigen processing and presentation,CREB1;TNF;CTSB,1.83E-03
B cell receptor signaling pathway,IKBKB;FOS;RELA,2.04E-03
Huntington disease,CREB1;BDNF;CASP3;TP53;SOD1,2.58E-03
Rheumatoid arthritis,IL6;FOS;TNF,3.02E-03
Aldosterone synthesis and secretion,POMC;CREB1;CALM2,3.50E-03
Choline metabolism in cancer,SLC22A4;FOS;HIF1A,3.50E-03
Hematopoietic cell lineage,IL4;IL6;TNF,3.60E-03
Rap1 signaling pathway,CNR1;NGF;CALM2;FGF2,4.10E-03
"Parathyroid hormone synthesis, secretion and action",CDKN1A;CREB1;FOS,4.36E-03
Thyroid cancer,CDKN1A;TP53,5.87E-03
"Growth hormone synthesis, secretion and action",GHSR;CREB1;FOS,6.02E-03
AMPK signaling pathway,CREB1;LEP;LEPR,6.16E-03
Bladder cancer,CDKN1A;TP53,7.17E-03
Tryptophan metabolism,MAOA;CAT,7.52E-03
Natural killer cell mediated cytotoxicity,IFNB1;CASP3;TNF,7.84E-03
Type I diabetes mellitus,TNF;IL2,7.87E-03
Type II diabetes mellitus,IKBKB;TNF,8.96E-03
Gastric cancer,CDKN1A;TP53;FGF2,1.11E-02
Cushing syndrome,POMC;CDKN1A;CREB1,1.24E-02
Endometrial cancer,CDKN1A;TP53,1.40E-02
VEGF signaling pathway,NOS3;PTGS2,1.44E-02
cGMP-PKG signaling pathway,CREB1;NOS3;CALM2,1.51E-02
Hepatocellular carcinoma,CDKN1A;GSTP1;TP53,1.53E-02
Arachidonic acid metabolism,PTGS2;PTGS1,1.54E-02
Steroid hormone biosynthesis,AKR1C1;COMT,1.54E-02
Basal cell carcinoma,CDKN1A;TP53,1.64E-02
Cortisol synthesis and secretion,POMC;CREB1,1.74E-02
Caffeine metabolism,XDH,1.85E-02
Fc epsilon RI signaling pathway,IL4;TNF,1.89E-02
Renal cell carcinoma,CDKN1A;HIF1A,1.94E-02
Central carbon metabolism in cancer,TP53;HIF1A,1.99E-02
Neutrophil extracellular trap formation,SELP;MPO;RELA,2.09E-02
Non-small cell lung cancer,CDKN1A;TP53,2.10E-02
Thyroid hormone synthesis,CREB1;ALB,2.27E-02
Gastric acid secretion,CA2;CALM2,2.33E-02
Metabolism of xenobiotics by cytochrome P450,AKR1C1;GSTP1,2.33E-02
Diabetic cardiomyopathy,PARP1;NOS3;RELA,2.51E-02
Insulin secretion,ADCYAP1;CREB1,2.93E-02
Hypertrophic cardiomyopathy,IL6;TNF,3.18E-02
Salivary secretion,NOS1;CALM2,3.38E-02
Staphylococcus aureus infection,IL10;SELP,3.51E-02
Inflammatory mediator regulation of TRP channels,NGF;CALM2,3.72E-02
Glucagon signaling pathway,CREB1;CALM2,4.36E-02
Cholinergic synapse,CREB1;FOS,4.80E-02
Nitrogen metabolism,CA2,5.14E-02
Phenylalanine metabolism,MAOA,5.14E-02
Thyroid hormone signaling pathway,TP53;HIF1A,5.43E-02
Cell cycle,CDKN1A;TP53,5.67E-02
Platelet activation,NOS3;PTGS1,5.67E-02
Systemic lupus erythematosus,IL10;TNF,6.58E-02
Histidine metabolism,MAOA,6.61E-02
Autophagy,HIF1A;CTSB,6.75E-02
Insulin signaling pathway,IKBKB;CALM2,6.75E-02
Proximal tubule bicarbonate reclamation,CA2,6.90E-02
Retrograde endocannabinoid signaling,CNR1;PTGS2,7.71E-02
Folate biosynthesis,TH,7.76E-02
Adrenergic signaling in cardiomyocytes,CREB1;CALM2,7.89E-02
Collecting duct acid secretion,CA2,8.05E-02
Phagosome,NOS1;MPO,8.08E-02
mTOR signaling pathway,IKBKB;TNF,8.26E-02
Phototransduction,CALM2,8.33E-02
Glyoxylate and dicarboxylate metabolism,CAT,8.90E-02
Circadian rhythm,CREB1,9.18E-02
Base excision repair,PARP1,9.75E-02
"Glycine, serine and threonine metabolism",MAOA,1.17E-01
Chemokine signaling pathway,IKBKB;RELA,1.19E-01
Ferroptosis,TP53,1.20E-01
Homologous recombination,RAD51,1.20E-01
Vasopressin-regulated water reabsorption,CREB1,1.28E-01
Ovarian steroidogenesis,PTGS2,1.47E-01
Fanconi anemia pathway,RAD51,1.55E-01
Thermogenesis,CREB1;CNR1,1.62E-01
Glutathione metabolism,GSTP1,1.62E-01
Long-term depression,NOS1,1.70E-01
Viral myocarditis,CASP3,1.70E-01
Long-term potentiation,CALM2,1.88E-01
Arrhythmogenic right ventricular cardiomyopathy,GJA1,2.13E-01
Complement and coagulation cascades,F3,2.32E-01
ErbB signaling pathway,CDKN1A,2.32E-01
Gap junction,GJA1,2.40E-01
Bile secretion,CA2,2.44E-01
Morphine addiction,OPRM1,2.47E-01
GnRH signaling pathway,CALM2,2.51E-01
TGF-beta signaling pathway,TNF,2.54E-01
Dilated cardiomyopathy,TNF,2.58E-01
Phosphatidylinositol signaling system,CALM2,2.61E-01
Pancreatic secretion,CA2,2.72E-01
Lysosome,CTSB,3.29E-01
Oocyte meiosis,CALM2,3.31E-01
Purine metabolism,XDH,3.31E-01
Vascular smooth muscle contraction,CALM2,3.39E-01
Signaling pathways regulating pluripotency of stem cells,FGF2,3.60E-01
Cell adhesion molecules,SELP,3.69E-01
Wnt signaling pathway,TP53,4.04E-01
Protein processing in endoplasmic reticulum,ATF6,4.13E-01
Regulation of actin cytoskeleton,FGF2,4.94E-01
Olfactory transduction,CALM2,7.49E-01
